Galmed’s business has been operating since 2000 under a different group of companies estab­lished in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incor­po­rated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Company Profile.

Galmed’s business has been operating since 2000 under a different group of companies estab­lished in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incor­po­rated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Company Profile.

Galmed Pharmaceuticals shares last traded at $3.44, with a volume of 181,852 shares changing hands. A number of research firms have recently issued […] A high-level overview of Galmed Pharmaceuticals Ltd. (GLMD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and  GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. Get Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

1. Hyresgästföreningen inneboendekontrakt mall
2. Namnhistoria efternamn
3. Ledig lägenhet stockholm
4. Luftstridsskolan julgransflygning

TEL AVIV, Israel, March 16, 2021-- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company today announced the treatment of the first subject in the First-in-Human Phase I clinical trial evaluating Amilo-5MER for the treatment of chronic inflammatory diseases. The Galmed Pharmaceuticals 52-week low stock price is 2.96, which is 15.4% below the current share price. The average Galmed Pharmaceuticals stock price for the last 52 weeks is 4.14 . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide .

A high-level overview of Galmed Pharmaceuticals Ltd. (GLMD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Buy today with a market order or use a limit order to delay your purchase until Galmed Pharmaceuticals … Stock analysis for Galmed Pharmaceuticals Ltd (GLMD:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 2021-03-18 2020-06-06 Based on 4 analysts offering 12 month price targets for Galmed Pharmaceuticals in the last 3 months. The average price target is $17.25 with a high forecast of $25.00 and a low forecast of $10.00. The average price target represents a 411.87% increase from the last price of $3.37.

Galmed Pharmaceuticals Ltd. stock was originally listed at a price of $14.31 in Mar 13, 2014. If you had invested in Galmed Pharmaceuticals Ltd stock at $14.31, your return over the last 7 years would have been -76.45%, for an annualized return of -18.66%.

Stock Symbol:.

All Rights Reserved. Investors Center News Events & Presentations SEC Filings Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information. Find real-time GLMD - Galmed Pharmaceuticals Ltd stock quotes, company profile, news and forecasts from CNN Business. Galmed Pharmaceuticals market value as of April 08, 2021 is $0.09B . Interactive chart of historical stock value for Galmed Pharmaceuticals over the last 10 years. The value of a company is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. TEL AVIV, Israel, Feb. 16, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory diseases, today announced that it is commencing an underwritten public offering of its Ordinary Shares (the "Offering").
Parkering tilläggstavla huvudled

Click here now Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. 2021-04-01 · View today's stock price, news and analysis for Galmed Pharmaceuticals Ltd. (GLMD). Barron's also provides information on historical stock ratings, target prices, company earnings, market Search for Galmed Pharmaceuticals. Find the stock by name or ticker symbol: GLMD. Research its history to confirm it's a solid investment against your financial goals.

Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $4.03 as of 1:30 PM on Tuesday, Feb 23, a loss of -$0.44, or -9.84% from the previous closing price of $4.47.
Orfordville wisconsin

unionen sj
naures atto
axivas deutschland gmbh
stämpla upp till heltid handels
reading recovery training
en ny regional planering

• HADc
• mg
• YX
• vDID
• in

• Strömsholms sadelmakeri öppettider
• Johan sundqvist stockholm
• Beverage barn
• Bostadslan rakna
• Ica group italy
• Borjesson forsta socialt arbete
• Vad är kärlek egentligen
• Amgo igaming 2021

Revenue growth over the past 12 months for Galmed Pharmaceuticals Ltd comes in at 336.4%, a number that bests 97.89% of the US stocks we're tracking. If you're looking for stocks that are quantitatively similar to Galmed Pharmaceuticals Ltd, a group of peers worth examining would be LJPC, ADXS, BLCM, OMER, and NOVN.

Research its history to confirm it's a solid investment against your financial goals.